Clinical Trials on Estrogen Receptor-positive Breast Cancer in Australia
Total 436 results
-
ExelixisActive, not recruitingA Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (STELLAR-001)Renal Cell Carcinoma | Colorectal Cancer | Metastatic Castration-resistant Prostate Cancer | Hormone Receptor Positive Breast Carcinoma | Neoplasm MalignantUnited States, Australia, Belgium, Czechia, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
Monopar TherapeuticsRecruitingGastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Lung Cancer | Bladder Cancer | Urothelial Carcinoma | Triple-negative Breast Cancer | Solid Tumor, AdultAustralia
-
Genor Biopharma Co., Ltd.Completed
-
Contact Asia PacificUnknown
-
Peter MacCallum Cancer Centre, AustraliaRecruitingMetastatic Triple Negative Breast CancerAustralia
-
Curtin UniversityActive, not recruiting
-
Novartis PharmaceuticalsCompletedAdvanced Triple Negative Breast Cancer (TNBC) With High TAMsFrance, Italy, Austria, Taiwan, United States, Spain, Australia, Korea, Republic of, Belgium, Germany, Hong Kong, Turkey
-
ExelixisRecruitingCervical Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Epithelial Ovarian Cancer | Metastatic Castration-resistant Prostate Cancer | Hormone Receptor-positive Breast Cancer | SCCHN | Esophageal SCC | Tissue Factor-Expressing Solid TumorsUnited States, Spain, Australia, Belgium, France, Italy, Netherlands, United Kingdom, Korea, Republic of
-
Olema Pharmaceuticals, Inc.PfizerRecruiting
-
Trans Tasman Radiation Oncology GroupActive, not recruitingBreast CancerAustralia, New Zealand
-
Arbeitsgemeinschaft medikamentoese TumortherapieGlaxoSmithKlineTerminatedMetastatic Breast CancerAustria
-
Medical University of ViennaUnknownMetastatic Breast CancerAustria
-
Uppsala UniversityRoyal Marsden NHS Foundation Trust; Uppsala University Hospital; Westmead Breast... and other collaboratorsRecruitingBreast Cancer | Breast Carcinoma in Situ | Breast Cancer Invasive | Breast AsymmetryUnited Kingdom, Sweden, Australia
-
Eli Lilly and CompanyCompletedMetastatic Breast CancerSpain, Australia, Belgium, Turkey, Russian Federation
-
Hoffmann-La RocheCompleted
-
R-PharmGlaxoSmithKlineTerminatedLocally Advanced or Metastatic Breast CancerUnited States, Italy, Australia
-
DualityBio Inc.BioNTech SERecruitingMetastatic Breast CancerUnited States, China, Australia
-
Eli Lilly and CompanyTerminatedBreast CancerMexico, France, Australia, Argentina, South Africa
-
Trans Tasman Radiation Oncology GroupPeter MacCallum Cancer Centre, AustraliaCompleted
-
St Vincent's Hospital, SydneyNovartisRecruitingBreast CancerAustralia
-
St George Hospital, AustraliaAstraZenecaUnknown
-
ETOP IBCSG Partners FoundationCompleted
-
Western Sydney Local Health DistrictSt George Hospital, AustraliaCompletedBreast Cancer | CYP2D6 PolymorphismAustralia
-
MacroGenicsCompletedHER-2 Positive Breast Cancer | Metastatic NeoplasmUnited States, Spain, Italy, Canada, Israel, Belgium, Germany, Czechia, Austria, Korea, Republic of, Denmark, United Kingdom, Portugal, France, Poland, Netherlands, Finland, Puerto Rico
-
Havah Therapeutics Pty LtdAstraZenecaUnknownBreast Cancer | Arthralgia | OsteoporosisAustralia
-
Hoffmann-La RocheTerminated
-
Central European Cooperative Oncology GroupTerminatedMetastatic Breast CancerHungary, Austria
-
Hoffmann-La RocheCompletedBreast Cancer, Colorectal Cancer, Gastric CancerAustria
-
Neovii BiotechTerminatedAdvanced Breast Cancer | Metastatic Breast CancerSpain, Austria, France, Germany, Italy
-
Barwon HealthUnknown
-
Trans Tasman Radiation Oncology Group3MCompleted
-
OncoSec Medical IncorporatedMerck Sharp & Dohme LLCActive, not recruitingTriple Negative Breast CancerUnited States, Australia
-
Medical University of ViennaDaiichi Sankyo, Inc.Recruiting
-
Bristol-Myers SquibbCompletedBreast CancerAustralia, Hungary, Canada, United Kingdom, Belgium
-
ETOP IBCSG Partners FoundationCompletedBreast CancerSwitzerland, Australia, Slovenia, Italy, Sweden, South Africa, New Zealand
-
ETOP IBCSG Partners FoundationCompleted
-
ETOP IBCSG Partners FoundationCompletedBreast CancerSwitzerland, Australia, Slovenia, Italy, Sweden, Hungary, Israel, South Africa, New Zealand
-
PureTechNovotech (Australia) Pty LimitedTerminatedLymphoedema | Breast Cancer Related LymphoedemaUnited States, Australia
-
IpsenTerminated
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerUnited States, Korea, Republic of, Spain, Brazil, Taiwan, Germany, Russian Federation, Australia
-
Medical University of GrazActive, not recruiting
-
Medical University of ViennaUniversity of Natural Resources and Life Sciences, Vienna, AustriaCompleted
-
Hoffmann-La RocheCompleted
-
AstraZenecaRecruitingER-Positive HER2-Negative Breast CancerUnited States, Israel, Spain, Korea, Republic of, Italy, Poland, Belgium, Norway, Bulgaria, France, Germany, United Kingdom, Japan, Taiwan, Canada, Hungary, Australia, Austria, Portugal, Turkey, Russian Federation, Slovakia, Switzer...
-
PfizerCompletedBreast CancerAustralia, India
-
Siemens Healthcare QTMedical University of ViennaCompletedBreast Cancer DiagnosisAustria
-
Johannes Kepler University of LinzCharles University, Czech Republic; Charite University, Berlin, Germany; German... and other collaboratorsRecruiting